Evotec 566480, wohin geht die Reise??? (Seite 6419)
eröffnet am 12.01.07 11:23:52 von
neuester Beitrag 02.05.24 17:20:03 von
neuester Beitrag 02.05.24 17:20:03 von
Beiträge: 82.042
ID: 1.104.790
ID: 1.104.790
Aufrufe heute: 7.225
Gesamt: 16.204.387
Gesamt: 16.204.387
Aktive User: 1
ISIN: DE0005664809 · WKN: 566480
9,9775
EUR
+3,02 %
+0,2925 EUR
Letzter Kurs 22:55:20 Lang & Schwarz
Neuigkeiten
Evotec Aktien jetzt im kostenlosen Demokonto handeln!Anzeige |
19:00 Uhr · Felix Haupt Anzeige |
18:43 Uhr · Shareribs Anzeige |
17:50 Uhr · wO Newsflash |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
4,1690 | +172,48 | |
1,6225 | +69,01 | |
2,9695 | +67,77 | |
1,7850 | +42,80 | |
1,1200 | +38,79 |
Wertpapier | Kurs | Perf. % |
---|---|---|
3,9200 | -16,60 | |
0,7500 | -16,67 | |
3,5000 | -26,24 | |
11,500 | -29,23 | |
0,5300 | -59,23 |
Beitrag zu dieser Diskussion schreiben
moin,
sieht vorbörslich schon gut aus bei 2,705 l und s
gruss
sieht vorbörslich schon gut aus bei 2,705 l und s
gruss
Antwort auf Beitrag Nr.: 43.645.746 von freiwilder am 26.09.12 07:38:34moin,
ich sage dir unserer gebete wurden erhört... toll !
gruss
ich sage dir unserer gebete wurden erhört... toll !
gruss
sehr schön das gibt ein gutes drittes quartal zusammen mit den 4 mil. us dollar aus cure beta! ;-)
Evotec erhält Meilensteinzahlung aus Forschungskooperation mit Boehringer Ingelheim
DGAP-News: Evotec AG / Schlagwort(e): Kooperation
Evotec erhält Meilensteinzahlung aus Forschungskooperation mit
Boehringer Ingelheim
26.09.2012 / 07:30
---------------------------------------------------------------------
Hamburg - 26. September 2012: Evotec AG (Frankfurter Wertpapierbörse: EVT,
TecDAX) gab heute bekannt, dass ihre Forschungsallianz mit Boehringer
Ingelheim einen Meilenstein erreicht hat, der eine Zahlung in Höhe von 2,5
Mio. EUR auslöst. Der Meilenstein wurde für die Überführung eines
Onkologie-Programms in die präklinische Profilierung erzielt.
Dr. Mario Polywka, Chief Operating Officer von Evotec kommentierte: 'Dies
ist der siebzehnte Meilenstein, der innerhalb unserer Allianz mit
Boehringer Ingelheim erreicht wurde. Er stellt einen wichtigen Übergang von
einer Substanz in die präklinische Profilierung dar. Wir freuen uns, dass
durch die hervorragende wissenschaftliche Zusammenarbeit zwischen Evotec
und Boehringer Ingelheim auch weiterhin erfolgreich Substanzen für die
klinische Entwicklung identifiziert werden.'
Evotec erhält Meilensteinzahlung aus Forschungskooperation mit Boehringer Ingelheim
DGAP-News: Evotec AG / Schlagwort(e): Kooperation
Evotec erhält Meilensteinzahlung aus Forschungskooperation mit
Boehringer Ingelheim
26.09.2012 / 07:30
---------------------------------------------------------------------
Hamburg - 26. September 2012: Evotec AG (Frankfurter Wertpapierbörse: EVT,
TecDAX) gab heute bekannt, dass ihre Forschungsallianz mit Boehringer
Ingelheim einen Meilenstein erreicht hat, der eine Zahlung in Höhe von 2,5
Mio. EUR auslöst. Der Meilenstein wurde für die Überführung eines
Onkologie-Programms in die präklinische Profilierung erzielt.
Dr. Mario Polywka, Chief Operating Officer von Evotec kommentierte: 'Dies
ist der siebzehnte Meilenstein, der innerhalb unserer Allianz mit
Boehringer Ingelheim erreicht wurde. Er stellt einen wichtigen Übergang von
einer Substanz in die präklinische Profilierung dar. Wir freuen uns, dass
durch die hervorragende wissenschaftliche Zusammenarbeit zwischen Evotec
und Boehringer Ingelheim auch weiterhin erfolgreich Substanzen für die
klinische Entwicklung identifiziert werden.'
Zitat von submersus: moin,
hoffe noch mal auf nachschlag, eine fette news in dieser woche wäre jetzt nicht schlecht dann hört endlich dieses rum geplänkel auf.....
Neue wirkungs stätte brauche ich nicht - aber mal überlegen, wird bestimmt gut bezahlt in hamburg ...
gruss
Habe gestern meine MOR-Anteile verkauft und in EVO umgeschichtet. Könnte mir vorstellen dass einige heute das Selbe getan haben. Ich denke mal dass morgen die 2,70 nachhaltig der Vergangenheit angehören könnte. Wenn dann noch eine Nachricht diese Woche kommt sind wir schnell bei 3 Euro
Antwort auf Beitrag Nr.: 43.641.528 von freiwilder am 25.09.12 09:37:53moin,
hoffe noch mal auf nachschlag, eine fette news in dieser woche wäre jetzt nicht schlecht dann hört endlich dieses rum geplänkel auf.....
Neue wirkungs stätte brauche ich nicht - aber mal überlegen, wird bestimmt gut bezahlt in hamburg ...
gruss
hoffe noch mal auf nachschlag, eine fette news in dieser woche wäre jetzt nicht schlecht dann hört endlich dieses rum geplänkel auf.....
Neue wirkungs stätte brauche ich nicht - aber mal überlegen, wird bestimmt gut bezahlt in hamburg ...
gruss
Ich gehe davon aus das dies die vorbereitungen für cure neuron sind!!!
[
quote=chiptrader;43641370]:-)
Posted: 20/09/2012 12:06
Start Date: Not Available
Salary: n/a
Location: Hamburg
Level: Management
Deadline: 28/09/2012 00:00
Hours: 40.00
Benefits: n/a
Job Type: Full Time, Permanent
Evotec is a leader in the discovery and development of novel small molecule drugs. It has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. The Company offers services and alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process.
We are seeking an enthusiastic and well-qualified
Project Director (m/f)
As Project Director, you will manage a multi-million dollar strategic collaboration with a US-based research organisation, focused on the discovery of novel drugs for the treatment of neurodegenerative disorders. This project comprises some 50 staff across both Medicinal Chemistry and Discovery Biology, executing diverse drug discovery activities including compound management, target ID and validation, lead finding and optimization, in vivo efficacy studies and biomarker studies. As Project Leader you will provide strong scientific guidance and expertise to the different project teams to facilitate the achievement of project goals, but also play a key role in managing the collaboration . You will liaise closely with functional management to ensure continuous and appropriate resource allocation and will be a member of the joint steering committee meeting to ensure that the project progresses in line with agreed plans. You will also have full responsibility for the project budget and the delivery on financial targets.
To succeed in this high-profile role you will have a PhD or equivalent in biochemistry, pharmacology, neuroscience or another relevant field, backed by >10 experience in CNS drug discovery, gained within the pharmaceutical or biotech industry. Prior knowledge of neurodegenerative disorders would be particularly relevant. You will have successfully led CNS projects from inception into pre-clinical development and through this, will have gained a wider understanding of all aspects of drug research and of key technologies You have gained substantial experience in managing teams of substantial size, either in a project or in a functional setting.
As Project Leader, you will demonstrate high energy and personal dynamism, as well as the organisational and planning skills required to guide this business-critical customer project. You will have the knowledge, experience and personal presence to rapidly build trust and respect both internally and externally. Able to operate with a high level of autonomy and independence, you will demonstrate strong operational skills combined with the ability to think strategically.
In return, Evotec offers the chance to expand and develop your career in a vigorous and exciting professional environment promoted by an open culture and a spirit of community.
We are curious to getting to know you and are looking forward to your application via our website http://www.evotec.com/articles/en/Careers/8
[/quote]
[
quote=chiptrader;43641370]:-)
Posted: 20/09/2012 12:06
Start Date: Not Available
Salary: n/a
Location: Hamburg
Level: Management
Deadline: 28/09/2012 00:00
Hours: 40.00
Benefits: n/a
Job Type: Full Time, Permanent
Evotec is a leader in the discovery and development of novel small molecule drugs. It has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. The Company offers services and alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process.
We are seeking an enthusiastic and well-qualified
Project Director (m/f)
As Project Director, you will manage a multi-million dollar strategic collaboration with a US-based research organisation, focused on the discovery of novel drugs for the treatment of neurodegenerative disorders. This project comprises some 50 staff across both Medicinal Chemistry and Discovery Biology, executing diverse drug discovery activities including compound management, target ID and validation, lead finding and optimization, in vivo efficacy studies and biomarker studies. As Project Leader you will provide strong scientific guidance and expertise to the different project teams to facilitate the achievement of project goals, but also play a key role in managing the collaboration . You will liaise closely with functional management to ensure continuous and appropriate resource allocation and will be a member of the joint steering committee meeting to ensure that the project progresses in line with agreed plans. You will also have full responsibility for the project budget and the delivery on financial targets.
To succeed in this high-profile role you will have a PhD or equivalent in biochemistry, pharmacology, neuroscience or another relevant field, backed by >10 experience in CNS drug discovery, gained within the pharmaceutical or biotech industry. Prior knowledge of neurodegenerative disorders would be particularly relevant. You will have successfully led CNS projects from inception into pre-clinical development and through this, will have gained a wider understanding of all aspects of drug research and of key technologies You have gained substantial experience in managing teams of substantial size, either in a project or in a functional setting.
As Project Leader, you will demonstrate high energy and personal dynamism, as well as the organisational and planning skills required to guide this business-critical customer project. You will have the knowledge, experience and personal presence to rapidly build trust and respect both internally and externally. Able to operate with a high level of autonomy and independence, you will demonstrate strong operational skills combined with the ability to think strategically.
In return, Evotec offers the chance to expand and develop your career in a vigorous and exciting professional environment promoted by an open culture and a spirit of community.
We are curious to getting to know you and are looking forward to your application via our website http://www.evotec.com/articles/en/Careers/8
[/quote]
Zitat von chiptrader: :-)
Posted: 20/09/2012 12:06
Start Date: Not Available
Salary: n/a
Location: Hamburg
Level: Management
Deadline: 28/09/2012 00:00
Hours: 40.00
Benefits: n/a
Job Type: Full Time, Permanent
Evotec is a leader in the discovery and development of novel small molecule drugs. It has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. The Company offers services and alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process.
We are seeking an enthusiastic and well-qualified
Project Director (m/f)
As Project Director, you will manage a multi-million dollar strategic collaboration with a US-based research organisation, focused on the discovery of novel drugs for the treatment of neurodegenerative disorders. This project comprises some 50 staff across both Medicinal Chemistry and Discovery Biology, executing diverse drug discovery activities including compound management, target ID and validation, lead finding and optimization, in vivo efficacy studies and biomarker studies. As Project Leader you will provide strong scientific guidance and expertise to the different project teams to facilitate the achievement of project goals, but also play a key role in managing the collaboration . You will liaise closely with functional management to ensure continuous and appropriate resource allocation and will be a member of the joint steering committee meeting to ensure that the project progresses in line with agreed plans. You will also have full responsibility for the project budget and the delivery on financial targets.
To succeed in this high-profile role you will have a PhD or equivalent in biochemistry, pharmacology, neuroscience or another relevant field, backed by >10 experience in CNS drug discovery, gained within the pharmaceutical or biotech industry. Prior knowledge of neurodegenerative disorders would be particularly relevant. You will have successfully led CNS projects from inception into pre-clinical development and through this, will have gained a wider understanding of all aspects of drug research and of key technologies You have gained substantial experience in managing teams of substantial size, either in a project or in a functional setting.
As Project Leader, you will demonstrate high energy and personal dynamism, as well as the organisational and planning skills required to guide this business-critical customer project. You will have the knowledge, experience and personal presence to rapidly build trust and respect both internally and externally. Able to operate with a high level of autonomy and independence, you will demonstrate strong operational skills combined with the ability to think strategically.
In return, Evotec offers the chance to expand and develop your career in a vigorous and exciting professional environment promoted by an open culture and a spirit of community.
We are curious to getting to know you and are looking forward to your application via our website http://www.evotec.com/articles/en/Careers/8
18:43 Uhr · Shareribs · EvotecAnzeige |
17:50 Uhr · wO Newsflash · Honeywell International |
09:47 Uhr · inv3st.de · BayerAnzeige |
04:45 Uhr · inv3st.de · BayerAnzeige |
01.05.24 · wO Newsflash · Amazon |
30.04.24 · BörsenNEWS.de · Evotec |
30.04.24 · Sharedeals · Evotec |
30.04.24 · Accesswire · Evotec |
Zeit | Titel |
---|---|
21:54 Uhr | |
13.02.24 | |
22.01.24 | |
17.01.24 | |
08.01.24 | |
15.05.23 |